Summit Securities Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.75M | Buy |
+97,762
| New | +$6.75M | 1.3% | 7 |
|
|
2023
Q4 | – | Sell |
-5,838
| Closed | -$531K | – | 631 |
|
|
2023
Q3 | $531K | Buy |
5,838
+5,000
| +597% | +$455K | 0.05% | 44 |
|
|
2023
Q2 | $68K | Sell |
838
-14,388
| -94% | -$1.17M | 0.01% | 236 |
|
|
2023
Q1 | $1.21M | Buy |
15,226
+11,556
| +315% | +$920K | 0.1% | 32 |
|
|
2022
Q4 | $248K | Buy |
+3,670
| New | +$248K | 0.01% | 274 |
|
|
2014
Q2 | – | Sell |
-23,000
| Closed | -$525K | – | 530 |
|
|
2014
Q1 | $525K | Buy |
+23,000
| New | +$525K | 0.31% | 50 |
|